Krueger Neil X, Reddy R Sreekantha, Johnson Karl, Bateman Jack, Kaufmann Nancy, Scalice Daniella, Van Vactor David, Saito Haruo
Dana-Farber Cancer Institute/Harvard Cancer Center, Harvard Medical School, Boston, Massachusetts 02115, USA.
Mol Cell Biol. 2003 Oct;23(19):6909-21. doi: 10.1128/MCB.23.19.6909-6921.2003.
The receptor protein tyrosine phosphatase (PTPase) Dlar has an ectodomain consisting of three immunoglobulin (Ig)-like domains and nine fibronectin type III (FnIII) repeats and a cytoplasmic domain consisting of two PTPase domains, membrane-proximal PTP-D1 and C-terminal PTP-D2. A series of mutant Dlar transgenes were introduced into the Drosophila genome via P-element transformation and were then assayed for their capacity to rescue phenotypes caused by homozygous loss-of-function genotypes. The Ig-like domains, but not the FnIII domains, are essential for survival. Conversely, the FnIII domains, but not the Ig-like domains, are required during oogenesis, suggesting that different domains of the Dlar ectodomain are involved in distinct functions during Drosophila development. All detectable PTPase activity maps to PTP-D1 in vitro. The catalytically inactive mutants of Dlar were able to rescue Dlar(-/-) lethality nearly as efficiently as wild-type Dlar transgenes, while this ability was impaired in the PTP-D2 deletion mutants DlarDeltaPTP-D2 and Dlar(bypass). Dlar-C1929S, in which PTP-D2 has been inactivated, increases the frequency of bypass phenotype observed in Dlar(-/-) genotypes, but only if PTP-D1 is catalytically active in the transgene. These results indicate multiple roles for PTP-D2, perhaps by acting as a docking domain for downstream elements and as a regulator of PTP-D1.
受体蛋白酪氨酸磷酸酶(PTPase)Dlar具有一个胞外结构域,该结构域由三个免疫球蛋白(Ig)样结构域和九个纤连蛋白III型(FnIII)重复序列组成,以及一个胞质结构域,该结构域由两个PTPase结构域组成,即膜近端的PTP-D1和C端的PTP-D2。通过P因子转化将一系列突变的Dlar转基因导入果蝇基因组,然后检测它们拯救由纯合功能丧失基因型引起的表型的能力。Ig样结构域对生存至关重要,而FnIII结构域并非如此。相反,在卵子发生过程中需要FnIII结构域,而不是Ig样结构域,这表明Dlar胞外结构域的不同结构域在果蝇发育过程中参与不同的功能。在体外,所有可检测到的PTPase活性都定位于PTP-D1。Dlar的催化无活性突变体能够几乎与野生型Dlar转基因一样有效地拯救Dlar(-/-)致死性,而这种能力在PTP-D2缺失突变体DlarDeltaPTP-D2和Dlar(bypass)中受损。其中PTP-D2已失活的Dlar-C1929S增加了在Dlar(-/-)基因型中观察到的旁路表型的频率,但前提是转基因中的PTP-D1具有催化活性。这些结果表明PTP-D2具有多种作用,可能是通过作为下游元件的对接结构域和PTP-D1的调节剂来实现的。